Miceli, D. D., Rey Amunategui, J. P., Pompili, G. A., Más, J., Pignataro, O. P., & Guitelman, M. (2026). Combined treatment of pegvisomant and cabergoline in a cat with hypersomatotropism: Insulin-like growth factor 1 normalization and control of comorbidities. Web
Citación estilo ChicagoMiceli, Diego Daniel, Juan P. Rey Amunategui, Gustavo A. Pompili, Javier Más, Omar Pedro Pignataro, and Mirtha Guitelman. Combined Treatment of Pegvisomant and Cabergoline in a Cat With Hypersomatotropism: Insulin-like Growth Factor 1 Normalization and Control of Comorbidities. 2026.
Cita MLAMiceli, Diego Daniel, et al. Combined Treatment of Pegvisomant and Cabergoline in a Cat With Hypersomatotropism: Insulin-like Growth Factor 1 Normalization and Control of Comorbidities. 2026.